← back to search

Bart N.M. van Berckel

Griffith University · AU
Area of research
Psychiatry and Mental health · Radiology, Nuclear Medicine and Imaging
Research interest
Research interests include Dementia and Cognitive Impairment Research, Alzheimer's disease research and treatments, Medical Imaging Techniques and Applications, and Advanced MRI Techniques and Applications.
h-index
73
citations
20,032
works
501
NIH funding
primary concept
email

Recent publications

Varying Levels of Inflammatory Activity in Brain and Body of Patients with Persistent Fatigue and Difficulty Concentrating After COVID-19: A TSPO PET Study
Journal of Nuclear Medicine 2025cited by 11position: middledoi
Neurobiological basis and risk factors of persistent fatigue and concentration problems after COVID-19: study protocol for a prospective case–control study (VeCosCO)
BMJ Open 2023cited by 12position: lastdoi
Comparing parametric methods for longitudinal measurement of β‐amyloid pathology with PET in elderly individuals
Alzheimer s & Dementia 2023cited by 0position: middledoi
Regional associations of white matter hyperintensities and early cortical amyloid pathology
Brain Communications 2022cited by 34position: middledoi
A 3D deep learning model to predict the diagnosis of dementia with Lewy bodies, Alzheimer’s disease, and mild cognitive impairment using brain 18F-FDG PET
European Journal of Nuclear Medicine and Molecular Imaging 2021cited by 75position: middledoi
White matter microstructure disruption in early stage amyloid pathology
Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring 2021cited by 42position: middledoi
ATN classification and clinical progression in subjective cognitive decline
Neurology 2020cited by 197position: middledoi
A nonsynonymous mutation in PLCG2 reduces the risk of Alzheimer’s disease, dementia with Lewy bodies and frontotemporal dementia, and increases the likelihood of longevity
Acta Neuropathologica 2019cited by 130position: middledoi
The P2X7 receptor tracer [11C]SMW139 as an in vivo marker of neuroinflammation in multiple sclerosis: a first-in man study
European Journal of Nuclear Medicine and Molecular Imaging 2019cited by 75position: middledoi
Prevalence of amyloid‐β pathology in distinct variants of primary progressive aphasia
Annals of Neurology 2018cited by 199position: middledoi
Prevalence of the apolipoprotein E ε4 allele in amyloid β positive subjects across the spectrum of Alzheimer's disease
Alzheimer s & Dementia 2018cited by 89position: middledoi
In vivo assessment of neuroinflammation in progressive multiple sclerosis: a proof of concept study with [18F]DPA714 PET
Journal of Neuroinflammation 2018cited by 84position: middledoi
Association of Cerebral Amyloid-β Aggregation With Cognitive Functioning in Persons Without Dementia
JAMA Psychiatry 2017cited by 148position: middledoi
The frequency and influence of dementia risk factors in prodromal Alzheimer's disease
Neurobiology of Aging 2017cited by 34position: middledoi
Atrophy, hypometabolism and clinical trajectories in patients with amyloid-negative Alzheimer’s disease
Brain 2016cited by 78position: middledoi
Prevalence of Cerebral Amyloid Pathology in Persons Without Dementia
JAMA 2015cited by 1,610position: middledoi
Prevalence of Amyloid PET Positivity in Dementia Syndromes
JAMA 2015cited by 663position: middledoi
The behavioural/dysexecutive variant of Alzheimer’s disease: clinical, neuroimaging and pathological features
Brain 2015cited by 554position: middledoi
Prevalence and prognosis of Alzheimer’s disease at the mild cognitive impairment stage
Brain 2015cited by 391position: middledoi
Atrophy patterns in early clinical stages across distinct phenotypes of <scp>A</scp>lzheimer's disease
Human Brain Mapping 2015cited by 257position: middledoi
Further human evidence for striatal dopamine release induced by administration of ∆9-tetrahydrocannabinol (THC): selectivity to limbic striatum
Psychopharmacology 2015cited by 130position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Frederik Barkhof · The Queen's Medical Research Institute7 papers (2015–2021)Philip Scheltens · University Hospital Cologne5 papers (2015–2021)Wiesje M. van der Flier · Alzheimer Nederland4 papers (2015–2020)Gil D. Rabinovici · Harvard University3 papers (2015–2016)William J. Jagust · Berkeley College3 papers (2015–2016)William W. Seeley · Hammersmith Hospital3 papers (2015–2016)Renaud La Joie · University Memory and Aging Center3 papers (2015–2016)Rik Ossenkoppele · Lund University3 papers (2015–2016)Bruce L. Miller · University at Buffalo, State University of New York3 papers (2015–2016)Anouk den Braber · Leiden University Medical Center2 papers (2020–2021)Adriaan A. Lammertsma · University of Groningen2 papers (2018–2019) · 2 papers (2018–2019)Howard J. Rosen · Medical University of South Carolina2 papers (2015–2015) · 2 papers (2018–2019)Joep Killestein · Palacký University Olomouc2 papers (2018–2019)Brendan I. Cohn‐Sheehy · University of California, Los Angeles2 papers (2015–2015)Jacob W. Vogel · Malmö University2 papers (2015–2015)Jori Tomassen · Amsterdam Neuroscience2 papers (2020–2021)Yolande A.L. Pijnenburg · University of Lausanne2 papers (2015–2015) · 2 papers (2018–2019)